Literature DB >> 11101869

Control of target cell survival in thyroid autoimmunity by T helper cytokines via regulation of apoptotic proteins.

G Stassi1, D Di Liberto, M Todaro, A Zeuner, L Ricci-Vitiani, A Stoppacciaro, L Ruco, F Farina, G Zummo, R De Maria.   

Abstract

After autoimmune inflammation, interactions between CD95 and its ligand (CD95L) mediate thyrocyte destruction in Hashimoto's thyroiditis (HT). Conversely, thyroid autoimmune processes that lead to Graves' disease (GD) result in autoantibody-mediated thyrotropin receptor stimulation without thyrocyte depletion. We found that GD thyrocytes expressed CD95 and CD95L in a similar manner to HT thyrocytes, but did not undergo CD95-induced apoptosis either in vivo or in vitro. This pattern was due to the differential production of TH1 and TH2 cytokines. Interferon gamma promoted caspase up-regulation and CD95-induced apoptosis in HT thyrocytes, whereas interleukin 4 and interleukin 10 protected GD thyrocytes by potent up-regulation of cFLIP and Bcl-xL, which prevented CD95-induced apoptosis in sensitized thyrocytes. Thus, modulation of apoptosis-related proteins by TH1 and TH2 cytokines controls thyrocyte survival in thyroid autoimmunity.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11101869     DOI: 10.1038/82725

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


  32 in total

1.  Regression of Peyer's patches in G alpha i2 deficient mice prior to colitis is associated with reduced expression of Bcl-2 and increased apoptosis.

Authors:  L Ohman; L Franzén; U Rudolph; L Birnbaumer; E Hultgren Hörnquist
Journal:  Gut       Date:  2002-09       Impact factor: 23.059

2.  Lymphocytes in peripheral blood and thyroid tissue in children with Graves' disease.

Authors:  Ben-Skowronek Iwona; Sierocinska-Sawa Jadwiga; Korobowicz Elzbieta; Szewczyk Leszek
Journal:  World J Pediatr       Date:  2008-12-23       Impact factor: 2.764

Review 3.  Cytokines, Graves' disease, and thyroid-associated ophthalmopathy.

Authors:  Andrew G Gianoukakis; Nicole Khadavi; Terry J Smith
Journal:  Thyroid       Date:  2008-09       Impact factor: 6.568

Review 4.  The consequences of apoptosis in autoimmunity.

Authors:  Ana Lleo; Carlo Selmi; Pietro Invernizzi; Mauro Podda; M Eric Gershwin
Journal:  J Autoimmun       Date:  2008-06-02       Impact factor: 7.094

5.  FOXO3 modulates endothelial gene expression and function by classical and alternative mechanisms.

Authors:  Tobias Czymai; Dorothee Viemann; Carsten Sticht; Grietje Molema; Matthias Goebeler; Marc Schmidt
Journal:  J Biol Chem       Date:  2010-02-01       Impact factor: 5.157

6.  Role of cytokines in the pathogenesis and suppression of thyroid autoimmunity.

Authors:  Balaji B Ganesh; Palash Bhattacharya; Anupama Gopisetty; Bellur S Prabhakar
Journal:  J Interferon Cytokine Res       Date:  2011-08-08       Impact factor: 2.607

7.  A double conundrum: concurrent presentation of Hashimoto's thyroiditis and ulcerative colitis.

Authors:  Gurpreet Singh; Susie Brien; Ellen Taylor
Journal:  BMJ Case Rep       Date:  2016-04-22

8.  Regulation of Apo2L/tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in thyroid carcinoma cells.

Authors:  Vassiliki Poulaki; Constantine S Mitsiades; Vassiliki Kotoula; Sophia Tseleni-Balafouta; Avi Ashkenazi; Demetrios A Koutras; Nicholas Mitsiades
Journal:  Am J Pathol       Date:  2002-08       Impact factor: 4.307

9.  A critical role for TRAIL in resolution of granulomatous experimental autoimmune thyroiditis.

Authors:  Y Fang; G C Sharp; H Yagita; H Braley-Mullen
Journal:  J Pathol       Date:  2008-12       Impact factor: 7.996

10.  Expression of IP-10/CXCL10 and MIG/CXCL9 in the thyroid and increased levels of IP-10/CXCL10 in the serum of patients with recent-onset Graves' disease.

Authors:  Paola Romagnani; Mario Rotondi; Elena Lazzeri; Laura Lasagni; Michela Francalanci; Andrea Buonamano; Stefano Milani; Paolo Vitti; Luca Chiovato; Massimo Tonacchera; Antonio Bellastella; Mario Serio
Journal:  Am J Pathol       Date:  2002-07       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.